Emergent BioSolutions
Specialized products to healthcare providers and governments to address
Maryland United States (HQ)
Emergent BioSolutions Company information
Edit Date
Employees
1,440 people
Ownership
Market cap
$7.0b
Net debt
$329m
Firm valuation
€6.6b (Public information from 2020)
| USD | 2016 | 2017 | 2018 | 2019 | 2020E | 2021E | 2022E |
|---|---|---|---|---|---|---|---|
| Revenues | - | 561m | 783m | 1.1b | 1.5b | 1.9b | 1.4b |
| % growth | - | - | 40 % | 41 % | 38 % | 23 % | (23 %) |
| EBITDA | - | 166m | 199m | 280m | 552m | 636m | - |
| % EBITDA margin | - | 30 % | 25 % | 25 % | 36 % | 34 % | - |
| Profit | - | 82m | 62m | 54m | 315m | 374m | - |
| % profit margin | - | 15 % | 8 % | 5 % | 21 % | 20 % | - |
| EV / Revenue | - | - | 4.7x | 3.1x | 4.8x | 3.7x | 4.6x |
| EV / EBITDA | - | - | 18.6x | 12.3x | 13.2x | 11.0x | 18.2x |
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | N/A | IPO | |
| N/A | $2m | DEBT | |
| N/A | $20m | GRANT | |
| Total Funding | Funding not available | ||
Recent News about Emergent BioSolutions
EditLocationEdit
1111 S Paca St, Baltimore, MD 21230, USA